Siegfried Reich
No más puestos en curso
Perfil
Siegfried Reich fundó eFFECTOR Therapeutics, Inc. El Dr. Reich es director científico y vicepresidente ejecutivo de Turning Point Therapeutics, Inc. En el pasado ocupó el cargo de Vicepresidente en Pfizer Inc. y Director y Jefe de Química Médica en Agouron Pharmaceuticals LLC (una filial de Pfizer Inc.), Vicepresidente Senior de Investigación en eFFECTOR Therapeutics, Inc. y Vicepresidente de Descubrimiento de Fármacos en SGX Pharmaceuticals, Inc. Siegfried Reich se licenció en la Universidad Estatal de San Diego y se doctoró en la Universidad de California, Irvine.
Antiguos cargos conocidos de Siegfried Reich.
Empresas | Cargo | Fin |
---|---|---|
TURG POIN | Chief Tech/Sci/R&D Officer | 04/03/2022 |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 18/04/2011 |
PFIZER, INC. | Corporate Officer/Principal | 01/12/2005 |
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Director/Board Member | 01/01/2001 |
EFFECTOR THERAPEUTICS, INC. | Founder | - |
Formación de Siegfried Reich.
San Diego State University | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
PFIZER, INC. | Health Technology |
EFFECTOR THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Agouron Pharmaceuticals LLC
Agouron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Agouron Pharmaceuticals LLC develops and distributes therapeutic products. It provides therapeutic products which are used in the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, inflammatory diseases, respiratory diseases, infectious diseases, immunological disorders, pharmaceutical preparations and other diseases. The company was founded in 1984 and is headquartered in San Diego, CA. | Health Technology |
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
eFFECTOR Therapeutics Operations, Inc.
eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Siegfried Reich